SCHEDULE 13G

Company

Cartesian Therapeutics, Inc.

Filed

June 30, 2017

Accession Number

0001615774-17-003435

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →